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A fully convergent one-pot two-step synthesis of different 
chiral 1,2,3-triazole-derived diols in high yields and excellent 
enantio- and diastereoselectivities is shown at very mild 
conditions in aqueous medium by combining a single alcohol 
dehydrogenase (ADH) with a Cu-catalysed ‘click’ reaction. 10 
Nowadays, the selective synthesis of enantioenriched derivatives 
for fine chemicals must go in hand with the design of sustainable 
processes.1 Hence, final targets must be obtained with excellent 
purities, but minimising the use of harmful solvents, reagents and 
also purification steps involved in a synthetic pathway.2 In this 15 
sense, the employment of water as reaction medium,3 recyclable 
catalysts4 and the design of one-pot multi-step sequential or 
concurrent synthesis5 are highly desired. In the last few years 
enzymes have been elegantly employed together with organo- or 
metal-catalyst(s), achieving (chemoenzymatic) one-pot multi-step 20 
synthesis of interesting compounds.6 Besides lipase-based dy-
namic processes,7,8 most of the examples deal with the concurrent 
use of oxidoreductases with organo-9 or metal-10 catalysts. For 
instance, alcohol dehydrogenases,11 responsible of the stereose-
lective reduction of carbonylic compounds, have been success-25 
fully combined with proline-9a or Zn-catalysed10b aldol reactions 
to obtain enantioenriched 1,3-diols, and with Pd-based catalysts 
for Wacker-Tsuji,10a Heck,10c,j Suzuki,10d,f,i or Suzuki-Miyaura10h 
reactions. In these examples, the non-enzymatic transformation 
occurred first to afford the non-isolated (di)ketone which further 30 
underwent ADH-catalysed reduction. 
 1,2,3-Triazoles are very important pharmacophores that can 
exert multiple biological activities,12 e.g., hydroxylated deriva-
tives have been described as potent β-adrenergic receptor block-
ers.13a Besides, triazole-containing structures are versatile ligands 35 
in coordination chemistry,13b and some related complexes have 
displayed antitumor activities.13c In this sense, the copper(I)-
catalysed version of the Huisgen cycloaddition in water between 
an alkyne and an azido compound to form them, is perhaps the 
most outstanding example of the so-called ‘click’ chemistry.14 A 40 
Cu(I) salt must be added into the reaction medium, but in the last 
few years, the in situ formation of this species by reduction of 
Cu(II) salts with, e.g. ascorbate, is mostly employed. Albeit more 
scarcely studied, comproportionation of a Cu(II) salt with Cu(0) 
is gaining more relevance due to availability and economic 45 
issues.15 Noteworthy, there are few examples in which biocataly-
sis and click chemistry have been combined in one-pot proce-
dures, although both protocols can be perfectly compatible. In 
this sense, it has been reported the kinetic resolution of aromatic 
epoxides by halohydrin dehalogenase (Hhe)-catalysed azidolysis, 50 
affording the corresponding β-azido alcohols that subsequently 
reacted with alkynes to achieve chiral 1,2,3-triazole alcohols.16 
Yields of these processes could be increased by introducing as a 
first step the bioreduction of an α-halo ketone.17 
 Herein, we envisaged a one-pot two-step fully convergent 55 
strategy in which, starting from two achiral compounds, a pair of 
suitable chiral precursors could be stereoselectively formed and 
then assembled by a ‘click’ reaction, giving rise to a single com-
pound bearing two chiral centres (Scheme 1). 
 60 
Scheme 1 One-pot two-step fully convergent strategy combining 
stereoselective enzymatic and metal-catalysed transformations. 
 The synthesis of the enantioenriched 1,2,3-triazole-derived 
diols was performed by the concurrent stereoselective bioreduc-
tion of an α-azido- and an alkynyl ketone, followed by cyclo-65 
addition catalysed by Cu(I) in situ formed via comproportionation 
of Cu(II) and Cu(0) (Scheme 2). 
 
Scheme 2 Chemoenzymatic protocol to synthesise enantioenriched 1,2,3-
triazole-derived diols. 70 
 Several practical issues were considered in advance: a) both 
ketones should be quantitatively reduced so, after the cycloaddi-
tion step, only diols must be formed, avoiding hydroxy ketones or 
diketones that would make the purification more complex; b) 
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alkynyl ketones may decompose in aqueous media,18 so the 
bioreduction step must be also quick and clean; c) the selectivity 
of the ADH-catalysed process must be high to avoid the for-
mation of diastereoisomers at the end of the sequence; d) the 
cycloaddition step must take place in the presence of the enzyme 5 
and the hydroalcoholic medium without loss of the performance; 
and e) it would be highly desirable that the Cu(0)-precatalyst 
source could be easily recycled with no stirring impairment. 
 In a first set of experiments, we studied the influence of diffe-
rent alkynones (1a-b) and α-azido ketones (1c-g) bearing ali-10 
phatic or aromatic (phenyl or 2-naphthyl) groups with, e.g. nitro 
or hydroxy moieties, on ADH-catalysed reductions using Prelog 
ADHs overexpressed in E. coli (ADH-A from Rhodococcus 
ruber,19 ADH-T from Thermoanaerobium sp.,20 and TesADH 
from Thermoanaerobacter ethanolicus21) or commercially avai-15 
lable anti-Prelog enzymes (LBADH from Lactobacillus brevis22 
or LKADH from Lactobacillus kefir23). In ADH-catalysed biore-
ductions, Tris.HCl buffer is usually a suitable medium, but it was 
observed that alkynones were not stable, so we turned to phos-
phate buffer 50 mM pH 7.5 at 30ºC and 250 rpm, in which these 20 
derivatives remained stable for longer periods. Under these con-
ditions, the reduction of all ketones was tested using ADHs 
(Table 1), showing in some cases quantitative conversions (c) and 
excellent stereoselectivities (ee). 
Table 1 Stereoselectivities in selected bioreductions of alkynones 1a-b 25 
and α-azido ketones 1c-g employing ADHs (t= 24 h)a 
 
Ketoneb E. coli/ 
ADH-A 
E. coli/ 
ADH-T 
E. coli/ 
TesADH 
LBADH LKADH 
1a 96 (S) 96 (S) 76 (S) 64 (R) - 
1bc 98 (R) 90 (R) 96 (R) >99 (S) 99 (S) 
1cc >99 (R) >99 (R) - >99 (S) 98 (S) 
1dc >99 (R) - - - - 
1ec 99 (R) 99 (R) - 99 (S) 99 (S) 
1fc >99 (R) >99 (R) - >99 (S) - 
1gc >99 (R) - - - - 
a For experimental details, see ESI. b In all cases where ee value appears, 
the conversion was quantitative. For incomplete reactions, see c and ee in 
Tables S1 and S2 in ESI. c Change in Cahn-Ingold-Prelog (CIP) priority. 30 
 Especially ADH-A as Prelog representative enzyme and 
LBADH as anti-Prelog counterpart rendered quantitative conver-
sions and excellent ee with several substrates. Furthermore, they 
were able to accept both alkynones and α-azido ketones, being 
excellent candidates to achieve the desired one-pot process. In a 35 
second stage, simultaneous bioreduction of a 1:1 mixture of 
alkynone/azido derivatives was tried to study if any interference 
could exist, either between reactants or with the ADH. Pleasingly, 
both substrates were perfectly reduced with the same values of 
stereoselectivity and no cross-inhibition was detected. 40 
 Later, the Cu-catalysed ‘click’ reaction was studied to find out 
suitable conditions. With this regard, the source of Cu(I) was 
firstly studied using as model substrates racemic alcohols rac-2a 
and rac-2c to afford a mixture of diols syn- and anti-3ac. 
CuSO4/ascorbic acid in a H2O:
tBuOH 1:1 v v-1 mixture was tried 45 
at room temperature for 24 h, but the conversion was not com-
plete. At this point, we envisaged a system that could be simple, 
economic and environmentally friendly to obtain Cu(I) via com-
proportionation using Cu wire with a catalytic amount of CuSO4. 
Thus, a copper wire was rolled on a magnetic bar (see ESI), 50 
allowing at the same time stirring, an easy recovery and its reuse 
along several cycles. Different solvent mixtures were tried 
(H2O:
tBuOH 1:1 v v-1; H2O:
iPrOH 1:1 v v-1; H2O:
iPrOH 95:5 v  
v-1) at 60ºC for 24 h, obtaining in all cases the triazole diols with 
quantitative conversions, but since the enzymatic step took place 55 
with iPrOH (5% v v-1),24 we chose the last setting to perform the 
sequential chemoenzymatic transformation. Microwave heating 
was also tried, but due to the formation of by-products, e.g. 1,5-
regioisomers,25 this methodology was not further investigated. 
After four cycles, the Cu wire got passivated, but it could be 60 
recovered by simple washing with HCl 2 N during 5 min. 
 In the final stage, the one-pot fully convergent chemoenzyma-
tic approach was achieved furnishing the 1,2,3-triazole-derived 
diols in good overall yields and excellent selectivities (Figure 1). 
After performing the bioreduction in phosphate buffer at 30ºC 65 
with 2-propanol for 24 h, the copper wire and CuSO4 were added 
into the reaction mixture, and it was heated up at 60ºC for 24 h. 
While with alkynone 1b diols syn-3 were obtained, in case of 
substrate 1a, since the enzyme recognised the ethynyl group as 
the ‘big’ moiety,26 anti-3 were synthesised. 70 
 
Figure 1 Examples of 1,2,3-triazole-derived diols synthesised using this 
chemoenzymatic approach. ee values correspond to the major 
diastereoisomer obtained. Isolated yields (69-85%) are relative to the 
diastereoisomeric mixture of the final diols. 75 
Conclusions 
In the last years, the combination of bio- and metal-catalysis has 
emerged as a potent tool to achieve the synthesis of novel deriva-
tives in a ‘one-pot’ fashion, thus avoiding the time-consuming 
and yield-lowering isolation of intermediates. In this sense, bio-80 
catalysed redox processes and copper(I)-catalysed [3+2] cyclo-
additions can be perfectly compatible in an environmentally 
benign medium like water. Herein it has been developed a one-
pot two-step fully convergent27 synthesis of different chiral 1,2,3-
triazole-derived diols in high yields and excellent enantio- and 85 
diastereoselectivities at very mild conditions. Hence, starting 
from two prochiral ketones and using a single ADH with iPrOH 
in a first step, and then applying a catalytic amount of CuSO4 and 
a Cu-wrapped stirring bar, a triazole core bearing two chiral 
centres could be easily synthesised. Moreover, the Cu(0)-preca-90 
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talyst could be recycled, easily removed, and remained active 
after several cycles. The possibility of the enzymatic recycling 
via immobilisation28 could also afford a more efficient and cost-
effective method. This system has also the advantage that by 
simple selection of the enzyme, the chirality of the final com-5 
pounds can be finely tuned. 
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